First dose to be delivered Monday in clinical trial for potential COVID-19 vaccine in the USA

Associated Press via MY9NJ ^ | 03/16/2020

[SeekAndFind]

A clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday, according to a government official.

The first participant in the trial will receive the experimental vaccine on Monday, the official said, speaking on the condition of anonymity because the trial has not been publicly announced yet. The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle, the official said.

Public health officials say it will take a year to 18 months to fully validate any potential vaccine.

Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.

Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines — shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed.

For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. The death toll in the United States is more than 50, while infections neared 3,000 across 49 states and the District of Columbia.

[A Navy Vet]

While I don’t dismiss the infectious nature of this virus, this sounds promising. Also read that plasma from recovered patients is a potential cure. It’s been used for years for polio and MS.. My question on another thread was how long it would be sure to cure and how long is the process for mass production. Nobody answered.

[reg45]

For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia.

So, shouldn’t these people be getting pneumonia vaccinations?

[Does so]

Yes. There are two, to be taken separately.

[DUMBGRUNT]

First dose to be delivered Monday

And the miles-long lines violating state health decrees, are attorneys and their place keepers.

Waiting to file uncountable lawsuits.

[Freeport]

From Inovio Pharmaceuticals information, they are going to start testing in April.

If that looks promising, since their process is different, with an emergency exemption, they can have 1,000,000 doses by the end of the year. Over that would require expansion of capacity/partners to grow the vaccine.

I would assume other vendors, like J&J and Giliad, who have vaccines under development, would have the same time frame.

The plasma method is effective for a short term immunity. It doesn’t seem to incur a long term effectiveness however. But in combination with a vaccine, would work. The problem seems to be obtaining a sufficient volume of cured patients to collect plasma from.

I read, I think on WebMD, that it takes several ‘CC’s of plasma per inoculation. The benefit last for upwards of a year, but not much longer, as I recall.

[WildHighlander57]

Thanks for the info!

[DownInFlames]

Pneumonia vaccine doesn’t work against corona. It’s a different strain.

[reg45]

Of course not, but it may prevent Corona sufferers from developing pneumonia.

[silverleaf]

Regular pneumonia vaccine has no effect on the Wuhan bioweapon
However it might be useful still against other types of pneumonia which will still be afflicting us

[I want the USA back]

The left is desperately looking for a way to trash Trump over this news.

[A Navy Vet]

Thanks for the info.

[Oldeconomybuyer]

A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle.